New Editorial Board (2017-18) – Widening the scope of the "Journal of Pharmaceutical Negative Research (JPNR)” into biomedical research

Abstract

The new editorial board of JPNR comprises two
associate editors and 26 editorial board members from
various biomedical, pharmaceutical, and biotechnological
field along with Editor-in-Chief. The new members
are having wider knowledge on recent trends of
biomedical and pharmaceutical research. In that, 12 are
subject-matter expert (SME) in field of pharmacology/
pharmaceutical sciences, 12 are SME in the field of
biomedical and clinical research, and 5 are SME in the
field of biotechnological research. The main objective of
the new editorial board member is to provide a platform
to document the negative findings/troubleshooting
methods of the research.